Cardiovascular and Renal Drugs Advisory Committee (CRDAC) in Joint
Session with the Drug Safety and Risk Management Advisory Committee (DSaRM)
SLIDES
September 12, 2007
George Shashaty, M.D
(ppt) (html)
Guest Speakers Presentations
Paul Corso, M.D (ppt) (html)
Keyvan Karkouti,
M.D., F.R.C.P.C., M.Sc (ppt) (html)
Dennis Mangano, M.D., Ph.D (ppt) (html)
Sponsor Presentations
Kemal Malik, M.D.,
Bayer Health Care Pharmaceuticals (ppt)
(html)
Sebastian
Schneeweiss, M.D., Sc.D, Harvard,
School
of
Public Health
(ppt) (html)
Pamela Cyrus, M.D.,
Bayer Pharmaceuticals Corporation (ppt)
(html)
Robert W. Makuch,
Ph.D., Yale,
School
of
Public Health
(ppt) (html)
Peter K. Smith, M.D.,
Duke
University
Medical
Center
(ppt) (html)
FDA Presentations
Rita
Ouellet-Hellstrom, Ph.D., M.P.H (ppt)
(html)
Mark Levenson, Ph.D (ppt) (html)
Chris Holland, M.S (ppt) (html)
Open Public Hearing Presentations
Niv Ad, M.D., Inova
Heart and Vascular Institute (ppt)
(html)
Anthony P. Furnary,
M.D.,
Providence St
Vincent
Hospital
(ppt) (html)
Up
| AC Home Page